240 related articles for article (PubMed ID: 33892503)
1. Transcriptomic Changes and the Roles of Cannabinoid Receptors and PPARγ in Developmental Toxicities Following Exposure to Δ9-Tetrahydrocannabinol and Cannabidiol.
Pandelides Z; Aluru N; Thornton C; Watts HE; Willett KL
Toxicol Sci; 2021 Jul; 182(1):44-59. PubMed ID: 33892503
[TBL] [Abstract][Full Text] [Related]
2. Developmental Effects of Cannabidiol and Δ9-Tetrahydrocannabinol in Zebrafish.
Carty DR; Thornton C; Gledhill JH; Willett KL
Toxicol Sci; 2018 Mar; 162(1):137-145. PubMed ID: 29106691
[TBL] [Abstract][Full Text] [Related]
3. Multigenerational consequences of early-life cannabinoid exposure in zebrafish.
Carty DR; Miller ZS; Thornton C; Pandelides Z; Kutchma ML; Willett KL
Toxicol Appl Pharmacol; 2019 Feb; 364():133-143. PubMed ID: 30594692
[TBL] [Abstract][Full Text] [Related]
4. Medium-throughput zebrafish optogenetic platform identifies deficits in subsequent neural activity following brief early exposure to cannabidiol and Δ
Kanyo R; Amin MR; Locskai LF; Bouvier DD; Olthuis AM; Allison WT; Ali DW
Sci Rep; 2021 Jun; 11(1):11515. PubMed ID: 34075141
[TBL] [Abstract][Full Text] [Related]
5. Toxicological properties of Δ9-tetrahydrocannabinol and cannabidiol.
Černe K
Arh Hig Rada Toksikol; 2020 Mar; 71(1):1-11. PubMed ID: 32597140
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
[TBL] [Abstract][Full Text] [Related]
7. Human osteoclasts in vitro are dose dependently both inhibited and stimulated by cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC).
Nielsen SSR; Pedersen JAZ; Sharma N; Wasehuus PK; Hansen MS; Møller AMJ; Borggaard XG; Rauch A; Frost M; Sondergaard TE; Søe K
Bone; 2024 Apr; 181():117035. PubMed ID: 38342278
[TBL] [Abstract][Full Text] [Related]
8. Botanically-Derived Δ
Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
[TBL] [Abstract][Full Text] [Related]
9. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
Dalterio S; Steger R; Mayfield D; Bartke A
Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
[TBL] [Abstract][Full Text] [Related]
10. Effects of a combination of cannabidiol and delta-9-tetrahydrocannabinol on key biological functions of HTR-8/SVneo extravillous trophoblast cells.
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Toxicology; 2023 Aug; 495():153614. PubMed ID: 37567336
[TBL] [Abstract][Full Text] [Related]
11. Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Thornton C; Dickson KE; Carty DR; Ashpole NM; Willett KL
Epilepsy Behav; 2020 Sep; 110():107152. PubMed ID: 32585475
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron development in zebrafish is altered by brief (5-hr) exposures to THC (∆
Ahmed KT; Amin MR; Shah P; Ali DW
Sci Rep; 2018 Jul; 8(1):10518. PubMed ID: 30002406
[TBL] [Abstract][Full Text] [Related]
13. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
14. Comment on Lachenmeier
Kruse D; Beitzke B
F1000Res; 2020; 9():900. PubMed ID: 32864108
[TBL] [Abstract][Full Text] [Related]
15. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of Δ8-THC, Δ9-THC, Cannabidiol and 10 Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS-MS.
Lin L; Amaratunga P; Reed J; Huang P; Lemberg BL; Lemberg D
J Anal Toxicol; 2022 Feb; 46(1):76-88. PubMed ID: 33270860
[TBL] [Abstract][Full Text] [Related]
19. Developmental exposure to cannabidiol (CBD) alters longevity and health span of zebrafish (Danio rerio).
Pandelides Z; Thornton C; Faruque AS; Whitehead AP; Willett KL; Ashpole NM
Geroscience; 2020 Apr; 42(2):785-800. PubMed ID: 32221778
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]